The answer from the studies
AOD-9604 changed fat in mice, not weight in people.
The main human trial found no extra weight loss over placebo. Animal results and safety gaps are kept clear.
The human study found no added weight loss
Does AOD-9604 help people lose weight? The main human study says no, and it tested this short protein chain. The chain copies the tail end of growth hormone.
In mice, the copied tail slowed new fat and burned some fat already stored. Those findings came from one mouse study. They don't show that people will lose weight.
The compound didn't send the full hormone's growth message or raise the IGF-1 blood growth signal. It isn't an approved drug or a food supplement. Sport rules also bar the compound.
For you, the human trial is the sound test, since animal findings can't replace that result. The effects page separates personal reports from study results. It also names the safety gaps.
AOD-9604 helped mice, then failed in people
AOD-9604 copies the fat-handling end of growth hormone, without sending the whole hormone's growth message. The IGF-1 blood growth signal also stayed unchanged [1]. These are two key differences from full growth hormone.
One lab study checked how new fat forms, and the copied hormone tail slowed that step [2]. In rat tissue, the copy slowed fat as much as full growth hormone. AOD-9604 didn't clearly free stored fat [3].
Another study treated obese mice for 14 days, and the mice lost weight and body fat. Their beta-3 control, which helps fat cells burn fuel, became more active. Mice born without that control didn't keep losing weight [4].
Researchers then studied about 900 obese adults, whose side effects were much like those with placebo [5]. The main larger trial found no extra weight loss. The company stopped the work around 2007 [9].
AOD-9604 copies only one hormone part
AOD-9604 is a peptide, or short protein chain, that copies growth hormone's tail [3]. One extra protein part sits at the front. Two links fasten together and bend the chain.
The compound isn't full growth hormone and doesn't tell the growth gland to release more. CJC-1295 is named only for contrast because that different peptide does tell the gland. AOD-9604 research explains why that matters.
Chemists have long names and file numbers that help them identify the right compound. Those labels don't show whether it works or stays safe. The human study gives you the useful answer.
No approved drug or dose exists
Is the compound approved for your care? No, and it isn't a food supplement either. The company stopped its drug work after the main trial failed [9]. The world sport authority bars it under its hormone-drug rule [6].
The FDA safety list places AOD-9604 under withdrawn compounding nominations. Withdrawal leaves the agency's safety concerns in place and does not authorize compounding. In U.S. prescription peptide care, a licensed clinician makes a separate decision on each request, including refusals; the state and treatment also limit what can be provided. The compounded medicine itself has no FDA approval.
The AOD-9604 references page names the published papers, and nothing on this site is sold. The pages don't give dose advice. Your own doctor can discuss your health.